202 related articles for article (PubMed ID: 17151595)
1. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.
do Rego JC; Orta MH; Leprince J; Tonon MC; Vaudry H; Costentin J
Neuropsychopharmacology; 2007 Jul; 32(7):1641-8. PubMed ID: 17151595
[TBL] [Abstract][Full Text] [Related]
2. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish.
Matsuda K; Wada K; Miura T; Maruyama K; Shimakura SI; Uchiyama M; Leprince J; Tonon MC; Vaudry H
Neuroscience; 2007 Dec; 150(2):425-32. PubMed ID: 17936516
[TBL] [Abstract][Full Text] [Related]
3. Detection, characterization and biological activities of [bisphospho-thr3,9]ODN, an endogenous molecular form of ODN released by astrocytes.
Gach K; Belkacemi O; Lefranc B; Perlikowski P; Masson J; Walet-Balieu ML; Do-Rego JC; Galas L; Schapman D; Lamtahri R; Tonon MC; Vaudry D; Chuquet J; Leprince J
Neuroscience; 2015 Apr; 290():472-84. PubMed ID: 25639232
[TBL] [Abstract][Full Text] [Related]
4. The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents.
de Mateos-Verchere JG; Leprince J; Tonon MC; Vaudry H; Costentin J
Eur J Pharmacol; 2001 Mar; 414(2-3):225-31. PubMed ID: 11239923
[TBL] [Abstract][Full Text] [Related]
5. The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors.
Do-Rego JL; Mensah-Nyagan AG; Beaujean D; Leprince J; Tonon MC; Luu-The V; Pelletier G; Vaudry H
J Neurochem; 2001 Jan; 76(1):128-38. PubMed ID: 11145985
[TBL] [Abstract][Full Text] [Related]
6. Gliotransmission and brain glucose sensing: critical role of endozepines.
Lanfray D; Arthaud S; Ouellet J; Compère V; Do Rego JL; Leprince J; Lefranc B; Castel H; Bouchard C; Monge-Roffarello B; Richard D; Pelletier G; Vaudry H; Tonon MC; Morin F
Diabetes; 2013 Mar; 62(3):801-10. PubMed ID: 23160530
[TBL] [Abstract][Full Text] [Related]
7. The octadecaneuropeptide exerts an anxiogenic-like action in goldfish.
Matsuda K; Wada K; Azuma M; Leprince J; Tonon MC; Sakashita A; Maruyama K; Uchiyama M; Vaudry H
Neuroscience; 2011 May; 181():100-8. PubMed ID: 21382452
[TBL] [Abstract][Full Text] [Related]
8. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability.
Cottone P; Sabino V; Steardo L; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1069-81. PubMed ID: 17077811
[TBL] [Abstract][Full Text] [Related]
9. The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.
Hamdi Y; Kaddour H; Vaudry D; Bahdoudi S; Douiri S; Leprince J; Castel H; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O
PLoS One; 2012; 7(8):e42498. PubMed ID: 22927932
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain.
Li S; Pelletier G
Neuroendocrinology; 1996 Aug; 64(2):79-84. PubMed ID: 8857601
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist.
Leprince J; Oulyadi H; Vaudry D; Masmoudi O; Gandolfo P; Patte C; Costentin J; Fauchère JL; Davoust D; Vaudry H; Tonon MC
Eur J Biochem; 2001 Dec; 268(23):6045-57. PubMed ID: 11732998
[TBL] [Abstract][Full Text] [Related]
12. Increased Hypothalamic Levels of Endozepines, Endogenous Ligands of Benzodiazepine Receptors, in a Rat Model of Sepsis.
Clavier T; Besnier E; Lefevre-Scelles A; Lanfray D; Masmoudi O; Pelletier G; Castel H; Tonon MC; Compère V
Shock; 2016 Jun; 45(6):653-9. PubMed ID: 26796573
[TBL] [Abstract][Full Text] [Related]
13. The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors.
Gandolfo P; Patte C; Leprince J; Thoumas JL; Vaudry H; Tonon MC
Eur J Pharmacol; 1997 Mar; 322(2-3):275-81. PubMed ID: 9098698
[TBL] [Abstract][Full Text] [Related]
14. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat.
Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
Brain Res Mol Brain Res; 2005 Nov; 141(2):156-60. PubMed ID: 16154662
[TBL] [Abstract][Full Text] [Related]
15. Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion.
Duparc C; Lefebvre H; Tonon MC; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5521-8. PubMed ID: 14602800
[TBL] [Abstract][Full Text] [Related]
16. The anorexigenic action of the octadecaneuropeptide (ODN) in goldfish is mediated through the MC4R- and subsequently the CRH receptor-signaling pathways.
Matsuda K; Kojima K; Wada K; Maruyama K; Leprince J; Tonon MC; Uchiyama M; Vaudry H
J Mol Neurosci; 2010 Sep; 42(1):74-9. PubMed ID: 20306309
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.
Rego JL; Leprince J; Luu-The V; Pelletier G; Tonon MC; Vaudry H
J Med Chem; 2007 Jun; 50(13):3070-6. PubMed ID: 17550241
[TBL] [Abstract][Full Text] [Related]
18. The endozepine ODN stimulates [3H]thymidine incorporation in cultured rat astrocytes.
Gandolfo P; Patte C; Thoumas JL; Leprince J; Vaudry H; Tonon MC
Neuropharmacology; 1999 May; 38(5):725-32. PubMed ID: 10340310
[TBL] [Abstract][Full Text] [Related]
19. In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain.
Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
Neuroscience; 2004; 125(2):411-5. PubMed ID: 15062983
[TBL] [Abstract][Full Text] [Related]
20. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
Berkovich A; McPhie P; Campagnone M; Guidotti A; Hensley P
Mol Pharmacol; 1990 Feb; 37(2):164-72. PubMed ID: 2154668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
